Home » Ranbaxy Receives US FDA Approval for Ramipril Capsules
Ranbaxy Receives US FDA Approval for Ramipril Capsules
Ranbaxy Laboratories announced that the company received US FDA approval for its abbreviated new drug application to market and manufacture Ramipril capsules of 5 mg and 10 mg strengths.
RTTNews
RTTNews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May